{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:16Z","timestamp":1787008756417,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"vor","delay-in-days":3014,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0\/uk\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"DOI":"10.1093\/eurheartj\/ehn299","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T20:34:33Z","timestamp":1215117273000},"page":"2031-2041","source":"Crossref","is-referenced-by-count":152,"title":["Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis"],"prefix":"10.1093","volume":"29","author":[{"given":"Gillian M.","family":"Sare","sequence":"first","affiliation":[{"name":"Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Gray","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.W.","family":"Bath","sequence":"additional","affiliation":[{"name":"Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,3]]},"reference":[{"key":"key\n\t\t\t\t20180328155913_EHN299C1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","article-title":"Treatment of menopausal symptoms: What shall we do now?","volume":"366","author":"Hickey","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328155913_EHN299C2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bone.2003.12.021","article-title":"Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: The PERF study","volume":"34","author":"Bagger","year":"2004","journal-title":"Bone"},{"key":"key\n\t\t\t\t20180328155913_EHN299C3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Postmenopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstein","year":"1996","journal-title":"NEJM"},{"key":"key\n\t\t\t\t20180328155913_EHN299C4","first-page":"90","article-title":"Cardiovascular disease in women: implications of hormone replacement therapy","volume":"41","author":"Sarrel","year":"1996","journal-title":"Int J Fert Menopausal Stud"},{"key":"key\n\t\t\t\t20180328155913_EHN299C5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328155913_EHN299C6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.GME.0000086467.82759.DA","article-title":"Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the national osteoporosis risk assessment (NORA) study","volume":"10","author":"Barrett-Connor","year":"2003","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20180328155913_EHN299C7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta analysis","volume":"330","author":"Bath","year":"2005","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C8","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328155913_EHN299C9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1521-690X(02)00079-9","article-title":"Hormone therapy and venous thromboembolism","volume":"17","author":"Peverill","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180328155913_EHN299C10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.maturitas.2007.02.007","article-title":"Hrt and the primary prevention of cardiovascular disease","volume":"57","author":"Stevenson","year":"2007","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20180328155913_EHN299C11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis","volume":"19","author":"Salpeter","year":"2004","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t20180328155913_EHN299C12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t20180328155913_EHN299C13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.jcbfm.9600270","article-title":"Estrogen and experimental ischemic stroke: a systematic review","volume":"26","author":"Gibson","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20180328155913_EHN299C14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/brain\/awm183","article-title":"Progesterone for the treatment of experimental brain injury: a systematic review","volume":"131","author":"Gibson","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180328155913_EHN299C15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/ENDO:29:2:209","article-title":"Mechanisms of neuroprotection by estrogen","volume":"29","author":"Suzuki","year":"2006","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t20180328155913_EHN299C16","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.107.509893","article-title":"Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published stroke trials","author":"Bath","year":"2008","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180328155913_EHN299C17","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1212\/WNL.53.8.1839","article-title":"Measuring quality of life in a way that is meaningful to stroke patients","volume":"53","author":"Williams","year":"1999","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328155913_EHN299C18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validating the validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00002512-199812050-00001","article-title":"Megatrials of hormonal replacement therapy","volume":"12","author":"Wren","year":"1998","journal-title":"Drugs Aging"},{"key":"key\n\t\t\t\t20180328155913_EHN299C20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/cmt.5.2.122.134","article-title":"Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials","volume":"5","author":"Zec","year":"2002","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t20180328155913_EHN299C21","doi-asserted-by":"crossref","first-page":"30F","DOI":"10.1016\/S0002-9149(01)02220-2","article-title":"Clinical cardiovascular studies of hormone replacement therapy","volume":"90","author":"Collins","year":"2002","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328155913_EHN299C22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002229.pub2","article-title":"Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women","author":"Gabriel","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"key\n\t\t\t\t20180328155913_EHN299C23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328155913_EHN299C24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bmj.39176.461227.80","article-title":"Composite and surrogate outcomes in randomised controlled trials","volume":"334","author":"Freemantle","year":"2007","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C25","first-page":"S3","article-title":"Optimising the analysis of stroke prevention trials (oast-p): assessment using ordered rather than dichotomous outcomes","volume":"20","author":"Geeganage","year":"2006","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t20180328155913_EHN299C26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180328155913_EHN299C27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/art.1780371014","article-title":"Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids","volume":"37","author":"Hall","year":"1994","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180328155913_EHN299C29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the women\u2019s international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"NEMJ"},{"key":"key\n\t\t\t\t20180328155913_EHN299C31","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effects of estrogen plus progestin on stroke in postmenopausal women. A women\u2019s health initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328155913_EHN299C32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy","volume":"291","author":"The Women\u2019s Health Initiative Steering Committee","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328155913_EHN299C33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1196\/annals.1365.031","article-title":"Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?","volume":"1092","author":"Rosano","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180328155913_EHN299C34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits","volume":"52","author":"Modena","year":"2005","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20180328155913_EHN299C35","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1056\/NEJM200012213432512","article-title":"Coronary heart disease in women","volume":"343","author":"Stevenson","year":"2000","journal-title":"NEJM"},{"key":"key\n\t\t\t\t20180328155913_EHN299C36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/0026-0495(93)90058-V","article-title":"Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy","volume":"42","author":"Godsland","year":"1993","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20180328155913_EHN299C37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm0397-324","article-title":"Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm","volume":"3","author":"Miyagawa","year":"1997","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328155913_EHN299C38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09513590600717368","article-title":"The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits\u2013an attempt to interpret the Women\u2019s Health Initiative results","volume":"22","author":"Kuhl","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180328155913_EHN299C39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328155913_EHN299C40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dyi285","article-title":"Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age","volume":"35","author":"Kim","year":"2006","journal-title":"Int J Epidemiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/29\/16\/2031\/17048429\/ehn299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:30:45Z","timestamp":1522279845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/29\/16\/2031\/409204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,3]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2008,7,3]]},"published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehn299","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,8]]},"published":{"date-parts":[[2008,7,3]]}}}